Delcath Systems, Inc. (DCTH) Stock Forecast 2026: P10, P50 & P90 — Probabli.AI
Timestamped DCTH stock forecast with 1-year P10, P50, and P90 price estimates, scenario probabilities, definitions, sources, and limitations.
Direct answer: Delcath Systems, Inc., despite recent downturns in stock price, has shown promising signs in terms of financial health and market opportunities. With robust clinical trials, an improved leadership team, and a suite of innovative oncology products, the company is well-positioned to capitalize on trends within its industry. That said, challenges such as regulatory hurdles and competitive pressures must be monitored diligently. The saved 1-year distribution is P10 $7, P50 $10, and P90 $13.
Last analyzed
Delcath Systems, Inc. Forecast data
| Estimate | 1-year price | Meaning |
|---|
| P10 | $7 | Pessimistic plausible scenario |
| P50 | $10 | Median scenario |
| P90 | $13 | Optimistic plausible scenario |
What the numbers mean
P10, P50, and P90 are model-generated scenario estimates: roughly a pessimistic plausible outcome, a median outcome, and an optimistic plausible outcome. They are not calibrated confidence intervals.
Supporting analysis
Given Delcath's recent positive news and efforts to strengthen its position in the health tech sector, it seems plausible that the company may experience growth. However, its 24h price drop signifies volatility and uncertainty, balancing the outlook.
Sources and limitations
Market and company inputs are primarily sourced through Yahoo Finance and public financial-data interfaces. This page reports a saved AI-generated scenario analysis as of the timestamp above; it is not live data, audited probability, financial advice, or a guaranteed return.
Frequently asked questions
When was this DCTH analysis generated?
March 4, 2026.
Is this a guaranteed DCTH prediction?
No. It is a model-generated scenario assessment with material uncertainty.
View the full DCTH stock analysis · DCTH sentiment · Methodology · Accuracy & validation
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.